Literature DB >> 16389130

Atrial fibrillation: public health implications.

Amy L Valderrama1, Sandra B Dunbar, George A Mensah.   

Abstract

BACKGROUND: Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia in the United States, affecting 2.3 million Americans. AF is associated with significant morbidity, mortality, and poor quality of life. AF and its treatments result in high healthcare resource use and costs.
OBJECTIVE: To develop a framework for public health action for the prevention, detection, and control of AF.
METHODS: A literature search was conducted via MEDLINE and CINAHL for the 1990-2004 period. Key words included atrial fibrillation, epidemiology, prevention, detection, treatment, and public health.
RESULTS: Published data predict a substantial increase in the prevalence of AF due to improved survival of people with coronary heart disease; increasing prevalence of hypertension, heart failure, and diabetes; and the aging of the American population. Low public awareness of AF and quality-of-care issues related to detection, control, and management are evident.
CONCLUSIONS: Awareness, early detection and treatment, improved patient self-management, and attention by public health programs are essential to reduce the burden of AF. Partnerships among professional nursing and medical organizations, the Centers for Disease Control and Prevention, and patient advocacy groups represent another important approach to improving public health outcomes for AF. Hospitalizations for AF and controversies over optimal treatment strategies (e.g., rate vs rhythm control) underscore the need for both public health and applied research.

Entities:  

Mesh:

Year:  2005        PMID: 16389130     DOI: 10.1016/j.amepre.2005.07.021

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN: 0749-3797            Impact factor:   5.043


  12 in total

1.  [Patients suffering from atrial fibrillation in Germany. Characteristics, resource consumption and costs].

Authors:  T Reinhold; S Rosenfeld; F Müller-Riemenschneider; S N Willich; T Meinertz; P Kirchhof; B Brüggenjürgen
Journal:  Herz       Date:  2012-08       Impact factor: 1.443

2.  Nonlinear and Stochastic Dynamics in the Heart.

Authors:  Zhilin Qu; Gang Hu; Alan Garfinkel; James N Weiss
Journal:  Phys Rep       Date:  2014-10-10       Impact factor: 25.600

3.  Management of stroke prevention in canadian patients with atrial fibrillation at moderate to high risk of stroke.

Authors:  William M Semchuk; Brandon Levac; Muria Lara; Annabelle Shakespeare; Thomas Evers; Jennifer Bolt
Journal:  Can J Hosp Pharm       Date:  2013-09

Review 4.  Rhythm control strategies and the role of antiarrhythmic drugs in the management of atrial fibrillation: focus on clinical outcomes.

Authors:  T Jared Bunch; Bernard J Gersh
Journal:  J Gen Intern Med       Date:  2010-11-25       Impact factor: 5.128

5.  Awareness of atrial fibrillation-effectiveness of a pilot national awareness campaign.

Authors:  Robert Briggs; Breffni Drumm; Ruth Dwyer; Des O'Neill; Sean P Kennelly; Tara Coughlan; Ronan Collins
Journal:  Ir J Med Sci       Date:  2019-06-29       Impact factor: 1.568

6.  Rhythm Control Vs Rate Control in a Contemporary Ambulatory Atrial Fibrillation Cohort: Post Hoc Analysis of the IMPACT-AF Trial.

Authors:  Arun Govindapillai; Jafna L Cox; Lehana Thabane; Steve Doucette; Feng Xie; James H MacKillop; Antonio Ciaccia; Shurjeel H Choudhri; Joanna M Nemis-White; Laura M Hamilton; Ratika Parkash
Journal:  CJC Open       Date:  2022-03-08

7.  Management of atrial fibrillation by primary care physicians in Germany: baseline results of the ATRIUM registry.

Authors:  Thomas Meinertz; Wilhelm Kirch; Ludger Rosin; David Pittrow; Stefan N Willich; Paulus Kirchhof
Journal:  Clin Res Cardiol       Date:  2011-05-01       Impact factor: 5.460

8.  Effects of pharmacologic therapy on health-related quality of life in elderly patients with atrial fibrillation: a systematic review of randomized and nonrandomized trials.

Authors:  Carl J Pepine
Journal:  Clin Med Insights Cardiol       Date:  2013-01-22

9.  Cardiovascular and non-cardiovascular hospital admissions associated with atrial fibrillation: a Danish nationwide, retrospective cohort study.

Authors:  Christine Benn Christiansen; Jonas Bjerring Olesen; Gunnar Gislason; Morten Lock-Hansen; Christian Torp-Pedersen
Journal:  BMJ Open       Date:  2013-01-24       Impact factor: 2.692

10.  One-year safety and quality of life outcomes in patients with atrial fibrillation on dronedarone: prospective, non-interventional study in German ambulatory care.

Authors:  Andreas Goette; G Benninger; D Pittrow; W D Paar; B von Stritzky; R F Bosch
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2015-03-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.